9 August 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice accepting six new medicines.

Avelumab (Bavencio) was accepted for the maintenance treatment of advanced urothelial carcinoma (bladder cancer).

Read SMC press release